Log In
Print
BCIQ
Print
Print this Print this
 

NeuVax, nelipepimut-S (E75)

  Manage Alerts
Collapse Summary General Information
Company Galena Biopharma Inc.
DescriptionVaccine consisting of an immunogenic peptide derived from epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu) and sargramostim
Molecular Target
Mechanism of ActionVaccine; Immunotherapy
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

4

$38.1M

0

$32.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today